• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL-9/STAT3/脂肪酸氧化介导的脂质过氧化作用导致 Tc9 细胞寿命延长和增强的抗肿瘤活性。

IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity.

出版信息

J Clin Invest. 2022 Apr 1;132(7). doi: 10.1172/JCI153247.

DOI:10.1172/JCI153247
PMID:35192544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8970676/
Abstract

CD8+ T cell longevity regulated by metabolic activity plays important roles in cancer immunotherapy. Although in vitro-polarized, transferred IL-9-secreting CD8+ Tc9 (cytotoxic T lymphocyte subset 9) cells exert greater persistence and antitumor efficacy than Tc1 cells, the underlying mechanism remains unclear. Here, we show that tumor-infiltrating Tc9 cells display significantly lower lipid peroxidation than Tc1 cells in several mouse models, which is strongly correlated with their persistence. Using RNA-sequence and functional validation, we found that Tc9 cells exhibited unique lipid metabolic programs. Tc9 cell-derived IL-9 activated STAT3, upregulated fatty acid oxidation and mitochondrial activity, and rendered Tc9 cells with reduced lipid peroxidation and resistance to tumor- or ROS-induced ferroptosis in the tumor microenvironment. IL-9 signaling deficiency, inhibiting STAT3, or fatty acid oxidation increased lipid peroxidation and ferroptosis of Tc9 cells, resulting in impaired longevity and antitumor ability. Similarly, human Tc9 cells also exhibited lower lipid peroxidation than Tc1 cells and tumor-infiltrating CD8+ T cells expressed lower IL9 and higher lipid peroxidation- and ferroptosis-related genes than circulating CD8+ T cells in patients with melanoma. This study indicates that lipid peroxidation regulates Tc9 cell longevity and antitumor effects via the IL-9/STAT3/fatty acid oxidation pathway and regulating T cell lipid peroxidation can be used to enhance T cell-based immunotherapy in human cancer.

摘要

CD8+T 细胞的代谢活性决定其寿命,在癌症免疫治疗中起着重要作用。虽然体外极化的分泌白细胞介素-9(IL-9)的 CD8+Tc9(细胞毒性 T 淋巴细胞亚群 9)细胞比 Tc1 细胞具有更强的持久性和抗肿瘤功效,但其中的机制仍不清楚。在这里,我们发现几种小鼠模型中,肿瘤浸润的 Tc9 细胞的脂质过氧化水平明显低于 Tc1 细胞,这与它们的持久性密切相关。通过 RNA 测序和功能验证,我们发现 Tc9 细胞表现出独特的脂质代谢程序。Tc9 细胞衍生的 IL-9 激活了 STAT3,上调了脂肪酸氧化和线粒体活性,使 Tc9 细胞减少了脂质过氧化,并在肿瘤微环境中对肿瘤或 ROS 诱导的铁死亡具有抗性。IL-9 信号缺失、抑制 STAT3 或脂肪酸氧化增加了 Tc9 细胞的脂质过氧化和铁死亡,导致其寿命缩短和抗肿瘤能力受损。同样,黑色素瘤患者肿瘤浸润的 CD8+T 细胞中表达的 IL9 较低,脂质过氧化和铁死亡相关基因较高,而循环 CD8+T 细胞中表达的 IL9 较低,脂质过氧化和铁死亡相关基因较高。这项研究表明,脂质过氧化通过 IL-9/STAT3/脂肪酸氧化途径调节 Tc9 细胞的寿命和抗肿瘤作用,调节 T 细胞的脂质过氧化可以用于增强人类癌症的基于 T 细胞的免疫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/17a88b41407b/jci-132-153247-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/fed62cab7b61/jci-132-153247-g041.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/995e0d6f07c0/jci-132-153247-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/af3964a0456d/jci-132-153247-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/11f1aa4115e2/jci-132-153247-g044.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/448d1e785354/jci-132-153247-g045.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/570143d08666/jci-132-153247-g046.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/17a88b41407b/jci-132-153247-g047.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/fed62cab7b61/jci-132-153247-g041.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/995e0d6f07c0/jci-132-153247-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/af3964a0456d/jci-132-153247-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/11f1aa4115e2/jci-132-153247-g044.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/448d1e785354/jci-132-153247-g045.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/570143d08666/jci-132-153247-g046.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3865/8970676/17a88b41407b/jci-132-153247-g047.jpg

相似文献

1
IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity.IL-9/STAT3/脂肪酸氧化介导的脂质过氧化作用导致 Tc9 细胞寿命延长和增强的抗肿瘤活性。
J Clin Invest. 2022 Apr 1;132(7). doi: 10.1172/JCI153247.
2
Cholesterol negatively regulates IL-9-producing CD8 T cell differentiation and antitumor activity.胆固醇负向调节产生 IL-9 的 CD8 T 细胞分化和抗肿瘤活性。
J Exp Med. 2018 Jun 4;215(6):1555-1569. doi: 10.1084/jem.20171576. Epub 2018 May 9.
3
IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells.IL-33 通过诱导 Tc9 细胞驱动树突状细胞的抗肿瘤作用。
Cell Mol Immunol. 2019 Jul;16(7):644-651. doi: 10.1038/s41423-018-0166-0. Epub 2018 Oct 1.
4
Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers.肿瘤特异性产生 IL-9 的 CD8+Tc9 细胞比 I 型细胞毒性 Tc1 细胞更适合用于癌症的过继免疫治疗。
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2265-70. doi: 10.1073/pnas.1317431111. Epub 2014 Jan 27.
5
CD36-mediated ferroptosis dampens intratumoral CD8 T cell effector function and impairs their antitumor ability.CD36 介导的铁死亡抑制肿瘤内 CD8 T 细胞效应功能,并损害其抗肿瘤能力。
Cell Metab. 2021 May 4;33(5):1001-1012.e5. doi: 10.1016/j.cmet.2021.02.015. Epub 2021 Mar 9.
6
Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation.Tc9 细胞,一种新型的 CD8(+) T 细胞亚群,支持 Th2 介导的气道炎症。
Eur J Immunol. 2013 Mar;43(3):606-18. doi: 10.1002/eji.201242825. Epub 2013 Jan 31.
7
STAT3 Activation-Induced Fatty Acid Oxidation in CD8 T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.信号转导和转录激活因子3(STAT3)激活诱导的CD8效应T细胞脂肪酸氧化对肥胖促进的乳腺肿瘤生长至关重要。
Cell Metab. 2020 Jan 7;31(1):148-161.e5. doi: 10.1016/j.cmet.2019.10.013. Epub 2019 Nov 21.
8
CD8 T cells regulate tumour ferroptosis during cancer immunotherapy.CD8 T 细胞在癌症免疫治疗中调节肿瘤铁死亡。
Nature. 2019 May;569(7755):270-274. doi: 10.1038/s41586-019-1170-y. Epub 2019 May 1.
9
Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.融合 Rab37/IL-6 转运和 STAT3/PD-1 转录轴引发免疫抑制性肺肿瘤微环境。
Theranostics. 2021 May 12;11(14):7029-7044. doi: 10.7150/thno.60040. eCollection 2021.
10
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.通过靶向脂肪酸转运蛋白 2 调节髓源性抑制细胞中的 ROS 增强抗 PD-L1 肿瘤免疫治疗。
Cell Immunol. 2021 Apr;362:104286. doi: 10.1016/j.cellimm.2021.104286. Epub 2021 Jan 19.

引用本文的文献

1
Multiple analytical perspectives of mitochondrial genes in the context of preeclampsia: potential diagnostic markers.子痫前期背景下线粒体基因的多种分析视角:潜在诊断标志物
Front Immunol. 2025 Jul 17;16:1595706. doi: 10.3389/fimmu.2025.1595706. eCollection 2025.
2
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
3
The Multifaceted Role of the IL-2 Cytokine Family in Melanoma: Mechanisms, Therapeutic Implications, and Immune Modulation.

本文引用的文献

1
Tumour fatty acid metabolism in the context of therapy resistance and obesity.治疗抵抗和肥胖背景下的肿瘤脂肪酸代谢
Nat Rev Cancer. 2021 Dec;21(12):753-766. doi: 10.1038/s41568-021-00388-4. Epub 2021 Aug 20.
2
CD8 T cell metabolism in infection and cancer.CD8 T 细胞代谢在感染和癌症中的作用。
Nat Rev Immunol. 2021 Nov;21(11):718-738. doi: 10.1038/s41577-021-00537-8. Epub 2021 May 12.
3
Cellular networks controlling T cell persistence in adoptive cell therapy.细胞网络控制过继细胞疗法中 T 细胞的持久性。
白细胞介素-2细胞因子家族在黑色素瘤中的多方面作用:机制、治疗意义及免疫调节
J Immunol Res. 2025 Jul 2;2025:8890939. doi: 10.1155/jimr/8890939. eCollection 2025.
4
The scaffold protein DLG4 facilitates RNF63-mediated ubiquitination and degradation of STAT3 in non-small cell lung cancer.支架蛋白DLG4促进RNF63介导的非小细胞肺癌中STAT3的泛素化和降解。
Cell Commun Signal. 2025 Jul 6;23(1):325. doi: 10.1186/s12964-025-02334-5.
5
Exploring T-cell metabolism in tuberculosis: development of a diagnostic model using metabolic genes.探索结核病中的T细胞代谢:利用代谢基因开发诊断模型
Eur J Med Res. 2025 Jun 16;30(1):483. doi: 10.1186/s40001-025-02768-0.
6
The role and mechanism of fatty acid oxidation in cancer drug resistance.脂肪酸氧化在癌症耐药中的作用及机制。
Cell Death Discov. 2025 Jun 13;11(1):277. doi: 10.1038/s41420-025-02554-1.
7
Emerging roles for fatty acid oxidation in cancer.脂肪酸氧化在癌症中的新作用。
Genes Dis. 2024 Dec 20;12(4):101491. doi: 10.1016/j.gendis.2024.101491. eCollection 2025 Jul.
8
Age- and diet-instructed metabolic rewiring of the tumor-immune microenvironment.年龄和饮食指导下的肿瘤免疫微环境代谢重塑。
J Exp Med. 2025 Jun 2;222(6). doi: 10.1084/jem.20241102. Epub 2025 Apr 11.
9
Metabolic reprogramming in T cell senescence: a novel strategy for cancer immunotherapy.T细胞衰老中的代谢重编程:癌症免疫治疗的新策略。
Cell Death Discov. 2025 Apr 9;11(1):161. doi: 10.1038/s41420-025-02468-y.
10
Adoptively transferred tumor-specific IL-9-producing cytotoxic CD8 T cells activate host CD4 T cells to control tumors with antigen loss.过继转移的产生肿瘤特异性白细胞介素-9的细胞毒性CD8 T细胞激活宿主CD4 T细胞以控制抗原缺失的肿瘤。
Nat Cancer. 2025 Apr;6(4):718-735. doi: 10.1038/s43018-025-00935-0. Epub 2025 Apr 3.
Nat Rev Immunol. 2021 Dec;21(12):769-784. doi: 10.1038/s41577-021-00539-6. Epub 2021 Apr 20.
4
CD36-mediated ferroptosis dampens intratumoral CD8 T cell effector function and impairs their antitumor ability.CD36 介导的铁死亡抑制肿瘤内 CD8 T 细胞效应功能,并损害其抗肿瘤能力。
Cell Metab. 2021 May 4;33(5):1001-1012.e5. doi: 10.1016/j.cmet.2021.02.015. Epub 2021 Mar 9.
5
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8 T Cells.药物筛选鉴定 CD8 T 细胞的代谢脆弱性。
Cancer Immunol Res. 2021 Feb;9(2):184-199. doi: 10.1158/2326-6066.CIR-20-0384. Epub 2020 Dec 4.
6
The Metabolic Underpinnings of Ferroptosis.铁死亡的代谢基础。
Cell Metab. 2020 Dec 1;32(6):920-937. doi: 10.1016/j.cmet.2020.10.011. Epub 2020 Nov 19.
7
Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9.通过极化人 T 细胞分泌白细胞介素-9增强对已建立肿瘤的 CAR-T 活性。
Nat Commun. 2020 Nov 19;11(1):5902. doi: 10.1038/s41467-020-19672-2.
8
Lymph protects metastasizing melanoma cells from ferroptosis.淋巴保护转移黑色素瘤细胞免受铁死亡。
Nature. 2020 Sep;585(7823):113-118. doi: 10.1038/s41586-020-2623-z. Epub 2020 Aug 19.
9
Metabolic conditioning of CD8 effector T cells for adoptive cell therapy.CD8 效应 T 细胞代谢调理用于过继细胞疗法。
Nat Metab. 2020 Aug;2(8):703-716. doi: 10.1038/s42255-020-0256-z. Epub 2020 Aug 3.
10
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.人类 DECR1 是一种雄激素受抑制的生存因子,可调节多不饱和脂肪酸氧化,以保护前列腺肿瘤细胞免受铁死亡。
Elife. 2020 Jul 20;9:e54166. doi: 10.7554/eLife.54166.